vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and OneStream, Inc. (OS). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $163.7M, roughly 1.1× OneStream, Inc.). OneStream, Inc. runs the higher net margin — 0.6% vs -0.7%, a 1.3% gap on every dollar of revenue. On growth, OneStream, Inc. posted the faster year-over-year revenue change (23.6% vs 0.7%). OneStream, Inc. produced more free cash flow last quarter ($25.6M vs $21.3M). Over the past eight quarters, OneStream, Inc.'s revenue compounded faster (21.8% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
AVNS vs OS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $163.7M |
| Net Profit | $-1.3M | $999.0K |
| Gross Margin | 47.5% | 69.8% |
| Operating Margin | 1.4% | -3.2% |
| Net Margin | -0.7% | 0.6% |
| Revenue YoY | 0.7% | 23.6% |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $-0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $163.7M | ||
| Q3 25 | $177.8M | $154.3M | ||
| Q2 25 | $175.0M | $147.6M | ||
| Q1 25 | $167.5M | $136.3M | ||
| Q4 24 | $179.6M | $132.5M | ||
| Q3 24 | $170.4M | $129.1M | ||
| Q2 24 | $171.7M | $117.5M | ||
| Q1 24 | $166.1M | $110.3M |
| Q4 25 | $-1.3M | $999.0K | ||
| Q3 25 | $-1.4M | $-8.8M | ||
| Q2 25 | $-76.8M | $-18.4M | ||
| Q1 25 | $6.6M | $-24.0M | ||
| Q4 24 | $-397.3M | — | ||
| Q3 24 | $4.3M | $-171.9M | ||
| Q2 24 | $1.8M | $-7.8M | ||
| Q1 24 | $-900.0K | $-5.0M |
| Q4 25 | 47.5% | 69.8% | ||
| Q3 25 | 48.4% | 68.1% | ||
| Q2 25 | 52.6% | 68.6% | ||
| Q1 25 | 53.6% | 68.0% | ||
| Q4 24 | 54.6% | 66.8% | ||
| Q3 24 | 54.5% | 50.1% | ||
| Q2 24 | 55.7% | 68.5% | ||
| Q1 24 | 57.1% | 69.1% |
| Q4 25 | 1.4% | -3.2% | ||
| Q3 25 | 0.1% | -11.3% | ||
| Q2 25 | -42.6% | -21.8% | ||
| Q1 25 | 6.1% | -29.3% | ||
| Q4 24 | -233.0% | -35.8% | ||
| Q3 24 | 7.0% | -197.6% | ||
| Q2 24 | 3.7% | -9.8% | ||
| Q1 24 | 2.4% | -4.9% |
| Q4 25 | -0.7% | 0.6% | ||
| Q3 25 | -0.8% | -5.7% | ||
| Q2 25 | -43.9% | -12.5% | ||
| Q1 25 | 3.9% | -17.6% | ||
| Q4 24 | -221.2% | — | ||
| Q3 24 | 2.5% | -133.1% | ||
| Q2 24 | 1.0% | -6.7% | ||
| Q1 24 | -0.5% | -4.5% |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-1.66 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-8.64 | — | ||
| Q3 24 | $0.09 | $-1.06 | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $693.6M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $504.7M |
| Total Assets | $1.1B | $1.0B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $693.6M | ||
| Q3 25 | $70.5M | $653.9M | ||
| Q2 25 | $90.3M | $652.1M | ||
| Q1 25 | $97.0M | $593.9M | ||
| Q4 24 | $107.7M | $544.2M | ||
| Q3 24 | $89.0M | $495.5M | ||
| Q2 24 | $92.2M | $140.5M | ||
| Q1 24 | $75.8M | — |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $504.7M | ||
| Q3 25 | $778.0M | $472.1M | ||
| Q2 25 | $776.3M | $458.2M | ||
| Q1 25 | $839.4M | $412.9M | ||
| Q4 24 | $828.5M | $386.2M | ||
| Q3 24 | $1.2B | $458.2M | ||
| Q2 24 | $1.2B | $97.5M | ||
| Q1 24 | $1.2B | $102.5M |
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.1B | $949.4M | ||
| Q2 25 | $1.0B | $910.5M | ||
| Q1 25 | $1.1B | $867.3M | ||
| Q4 24 | $1.2B | $823.2M | ||
| Q3 24 | $1.7B | $750.1M | ||
| Q2 24 | $1.7B | $379.7M | ||
| Q1 24 | $1.7B | — |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $25.8M |
| Free Cash FlowOCF − Capex | $21.3M | $25.6M |
| FCF MarginFCF / Revenue | 11.8% | 15.7% |
| Capex IntensityCapex / Revenue | 3.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 25.79× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $95.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $25.8M | ||
| Q3 25 | $14.0M | $5.0M | ||
| Q2 25 | $6.8M | $29.7M | ||
| Q1 25 | $25.7M | $36.2M | ||
| Q4 24 | $57.9M | — | ||
| Q3 24 | $23.0M | $2.4M | ||
| Q2 24 | $27.8M | $8.1M | ||
| Q1 24 | $-8.0M | $25.5M |
| Q4 25 | $21.3M | $25.6M | ||
| Q3 25 | $7.0M | $4.8M | ||
| Q2 25 | $-4.2M | $29.4M | ||
| Q1 25 | $19.0M | $35.8M | ||
| Q4 24 | $53.1M | — | ||
| Q3 24 | $20.0M | $1.3M | ||
| Q2 24 | $21.9M | $7.7M | ||
| Q1 24 | $-12.1M | $24.9M |
| Q4 25 | 11.8% | 15.7% | ||
| Q3 25 | 3.9% | 3.1% | ||
| Q2 25 | -2.4% | 19.9% | ||
| Q1 25 | 11.3% | 26.3% | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 11.7% | 1.0% | ||
| Q2 24 | 12.8% | 6.6% | ||
| Q1 24 | -7.3% | 22.5% |
| Q4 25 | 3.8% | 0.1% | ||
| Q3 25 | 3.9% | 0.1% | ||
| Q2 25 | 6.3% | 0.2% | ||
| Q1 25 | 4.0% | 0.3% | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 1.8% | 0.8% | ||
| Q2 24 | 3.4% | 0.3% | ||
| Q1 24 | 2.5% | 0.6% |
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
